Alan S. Roemer - 21 Dec 2021 Form 4 Insider Report for NexImmune, Inc.

Role
Director
Signature
/s/ Ilse Johnson, Attorney-in-fact
Issuer symbol
NEXI on OTC
Transactions as of
21 Dec 2021
Net transactions value
+$245,867
Form type
4
Filing time
22 Dec 2021, 16:00:22 UTC
Previous filing
23 Nov 2021
Next filing
23 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Options Exercise $30,574 +12,634 +9.9% $2.42* 140,618 21 Dec 2021 Direct
transaction NEXI Common Stock Options Exercise $32,596 +12,634 +9% $2.58* 153,252 21 Dec 2021 Direct
transaction NEXI Common Stock Options Exercise $182,697 +42,389 +28% $4.31* 195,641 21 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEXI Stock Option (right to buy) Options Exercise $0 -12,634 -100% $0.000000* 0 21 Dec 2021 Common Stock 12,634 $2.42 Direct F1
transaction NEXI Stock Option (right to buy) Options Exercise $0 -12,634 -100% $0.000000* 0 21 Dec 2021 Common Stock 12,634 $2.58 Direct F1
transaction NEXI Stock Option (right to buy) Options Exercise $0 -42,389 -92% $0.000000 3,856 21 Dec 2021 Common Stock 42,389 $4.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All shares underlying this option have vested.
F2 33.33% of the shares vested on March 19, 2020; the remainder vests monthly on the 19th of every month until March 19, 2022.